Home Home Home Inbox Home Search

Event

Effectiveness and Safety of Direct Switch to Indacaterol/Glycopyrronium from Previous Treatments in Patients with Moderate-to-Severe COPD: The POWER Study [Board No. P1335]

Location: Board no. P1335
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Driss Rochdi

PhD
Novartis Pharma Canada Inc.

Michel Djandji

MD
Novartis Pharma Canada Inc.

David Prefontaine

PhD
Novartis Pharma Canada Inc.

Andrew McIvor

MD
McMaster University, Firestone Institute for Respiratory Health

Kenneth Chapman

MD
Asthma & Airway Centre, UHN and University of Toronto;University Health Network, University of Toronto;University of Toronto

Irvin Mayers

MD
University of Alberta

Syed M. Anees

MD
Schulich School of Medicine & Dentistry- Windsor Campus

Alan Kaplan

MD
Family Physician Airways Group of Canada;University of Toronto

View Abstract

Effectiveness and Safety of Direct Switch to Indacaterol/Glycopyrronium from Previous Treatments in Patients with Moderate-to-Severe COPD: The POWER Study

Parent Sessions

  • B33 - COPD: MAINTENANCE THERAPY
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search